https://orcid.org/0000-0003-1056-729X
Figures
Abstract
Objective
To describe the patient population, priority diseases and outcomes in newborns admitted <48 hours old to neonatal units in both Kenya and Nigeria.
Study design
In a network of seven secondary and tertiary level neonatal units in Nigeria and Kenya, we captured anonymised data on all admissions <48 hours of age over a 6-month period.
Results
2280 newborns were admitted. Mean birthweight was 2.3 kg (SD 0.9); 57.0% (1214/2128) infants were low birthweight (LBW; <2.5kg) and 22.6% (480/2128) were very LBW (VLBW; <1.5 kg). Median gestation was 36 weeks (interquartile range 32, 39) and 21.6% (483/2236) infants were very preterm (gestation <32 weeks). The most common morbidities were jaundice (987/2262, 43.6%), suspected sepsis (955/2280, 41.9%), respiratory conditions (817/2280, 35.8%) and birth asphyxia (547/2280, 24.0%). 18.7% (423/2262) newborns died; mortality was very high amongst VLBW (222/472, 47%) and very preterm infants (197/483, 40.8%). Factors independently associated with mortality were gestation <28 weeks (adjusted odds ratio 11.58; 95% confidence interval 4.73–28.39), VLBW (6.92; 4.06–11.79), congenital anomaly (4.93; 2.42–10.05), abdominal condition (2.86; 1.40–5.83), birth asphyxia (2.44; 1.52–3.92), respiratory condition (1.46; 1.08–2.28) and maternal antibiotics within 24 hours before or after birth (1.91; 1.28–2.85). Mortality was reduced if mothers received a partial (0.51; 0.28–0.93) or full treatment course (0.44; 0.21–0.92) of dexamethasone before preterm delivery.
Citation: Nabwera HM, Wang D, Tongo OO, Andang’o PEA, Abdulkadir I, Ezeaka CV, et al. (2021) Burden of disease and risk factors for mortality amongst hospitalized newborns in Nigeria and Kenya. PLoS ONE 16(1): e0244109. https://doi.org/10.1371/journal.pone.0244109
Editor: Prem Singh Shekhawat, Metrohealth Medical Center, UNITED STATES
Received: June 13, 2020; Accepted: December 2, 2020; Published: January 14, 2021
Copyright: © 2021 Nabwera et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information file.
Funding: This project was completed as part of the Neonatal Nutrition Network, funded by a grant from the MRC Confidence in Global Nutrition and Health Research scheme, awarded to SJA (grant reference MC_PC_MR/R019789/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Globally, 2.5 million infants died in the neonatal period (before age 28 days) in 2018. Neonatal deaths accounted for 47% of all under 5 deaths and this proportion is increasing [1]. The majority of neonatal deaths occur in the first week of life and are preventable with equitable access to adequate, evidence-based maternal and newborn health care [2]. Sub-Saharan Africa (SSA) bears a high burden of adverse neonatal outcomes and is the region where the least progress has been made in addressing neonatal morbidity and mortality [1, 3]. The third Sustainable Development Goal emphasises the need to end preventable newborn deaths with a target for all countries to reduce the neonatal mortality rate (NMR) to 12 per 1000 live births or lower by 2030 [4].
Globally, preterm (gestation <37 weeks) and low birthweight (LBW; <2.5 kg) infants have an increased risk of mortality in the neonatal and post neonatal periods [5, 6]. Over 97% of these infants are born in resource-limited settings [5, 7–9]. Indeed, complications of preterm birth are now the leading cause of under 5 deaths accounting for 18% [1, 10]. Intrapartum-related events and neonatal sepsis are other major causes of under 5 mortality [1].
Nigeria and Kenya are both ranked as lower-middle income countries by the United Nations [11]. The NMR has halved in both countries over the past five decades but they remain amongst the countries with the highest NMR in SSA, with the estimated NMR in 2018 in Nigeria of 39 per 1000 live births and in Kenya 19.6 per 1,000 live births [12, 13]. Both countries are unlikely to meet the SDG target at their current rate of progress [3].
Reliable estimates of underlying causes of newborn morbidity and mortality are a pre-requisite for evidence-based policy-making, advocacy and priority setting for future research [14]. Unfortunately, in many SSA countries including Nigeria and Kenya, health information systems are inadequate [15, 16]. Routine clinical data on common, serious neonatal conditions such as preterm birth, low birthweight (LBW), birth asphyxia, sepsis and respiratory disorders in hospitalised infants are sparse [17–19]. This lack of routine patient data, alongside the limited engagement of health professionals managing these infants in research, inhibits the development of context relevant strategies and novel interventions to improve outcomes.
We established the Neonatal Nutrition Network (NeoNuNet) consisting of five neonatal units (NNUs) in Nigeria and two in Kenya to share expertise and experience to improve clinical outcomes across the Network and provide a platform for the development and evaluation of nutrition and other key interventions for the most at risk preterm/LBW infants. In the first phase a shared database of anonymised routine clinical data was therefore established to describe the patient population, priority diseases and outcomes in newborns admitted <48 hours old to inform the development of context-relevant interventions in these SSA NNUs.
Methods
Ethics approval
The study was approved by the Research and Ethics Committee at the Liverpool School of Tropical Medicine (protocol number:18–0210), The Lagos University Teaching Hospital Health Research Ethics Committee (protocol number: AMD/DCST/HREC/APP/2514), The Kenya Medical Research Institute-Scientific and Ethics Review Unit (protocol number: KEMRI/SERU/CGMR-C/120/3740) and the research and ethics committees at The Jaramogi Oginga Odinga Teaching and Referral Hospital (protocol number: ERC.IB/VOL.1/510), University College Hospital Ibadan (protocol number: UI/EC/18/0446), Massey Street Children’s Hospital (protocol number: LSHSC/2222/VOL.VIB/185), Ahmadu Bello University Teaching Hospital (ABUTH/HZ/HREC/D37/2018), and Maitama District Hospital (protocol number: FHREC/2018/01/108/19-09-18).
Study setting
The study was conducted in five NNUs in Nigeria of which four provide tertiary level care (University College Hospital, Ibadan; Lagos University Teaching Hospital, Massey Children’s Hospital, Lagos; Ahmadu Bello University Teaching Hospital, Zaria) and one secondary level neonatal care (Maitama District Hospital, Abuja) and two in Kenya: Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu providing tertiary level and Kilifi County Referral Hospital secondary level neonatal care. In Nigeria, the Nigeria Society of Neonatal Medicine led in the selection of these facilities and aimed to incorporate neonatal units from both the northern and southern parts of the country. In Kenya, the facilities were chosen based on previous collaborative partnerships aiming to include neonatal units that provide different levels of care i.e. tertiary and district level in different regions of the country. The basis of this selection process was prior research and clinical training collaborative partnerships between the Liverpool School of Tropical Medicine (LSTM) co-investigators and clinical researchers in Nigeria and Kenya. All neonatal units admitted both inborn and outborn infants <28 days of age. All neonatal units except one in Kenya had separate rooms/wards for admitting inborn and outborn neonates. The tertiary level units typically had 2–4 consultant neonatologists or paediatricians who supervised resident doctors/registrars, intern house officers, clinical officers and a team of 1–3 nurses per shift. In all the units, the neonates were admitted by intern house officers, medical officers or clinical officers and were reviewed by a consultant neontologist or paediatrician daily during their admission. The bed capacity ranged from 24–80 but occupancy often exceeded 100%. The district level NNUs had 1–3 consultant paediatricians who worked with medical officers, clinical officers and a team of 2–3 nurses per shift. The bed capacity ranged from 12–27. The NNUs provide care according to institutional neonatal protocols in Nigeria and the Kenya national paediatric protocol [20]. All the NNUs had access to oxygen, pulse oximetry and phototherapy but these were often limited in availability and, therefore, reserved for the sickest newborns. All the tertiary level NNUs and one of the district level NNUs used non-invasive ventilation (i.e. continuous positive airway pressure), but none used endotracheal ventilation.
Study design, study population and data collection
This was a multi-centre, prospective, observational study. During network meetings held before data collection, we established a standardised case report form (CRF) and an anonymised demographic/clinical database. Clinical criteria, laboratory analyses and imaging currently used for the diagnosis of common neonatal morbidities were reviewed and additional CRFs developed to capture episodes of suspected sepsis, respiratory problems, abdominal conditions and birth asphyxia diagnosed according to current clinical practice in each NNU. The CRFs are available from https://www.lstmed.ac.uk/nnu. All newborns aged <48 hours admitted to each NNU over a 6-month period between August 2018 and May 2019 were included in the study and had CRFs completed with the period of data collection determined by timing of ethics approval. Infants who were ≥ 48 hours of age at admission were excluded because we wanted to optimize recall of information on feeding practices from birth. In addition, infants aged 48 hours and above were generally admitted to paediatric wards rather than neonatal units. Details of maternal demography, socioeconomic status, health and the current pregnancy were recorded from ante-natal records. Details of labour and delivery were collected from hospital records. Paper CRFs were kept as part of infant case records or stored separately and updated during NNU admission. Details of clinical criteria used to diagnose infant conditions were recorded in separate forms, the analyses of which are provided in a separate manuscript that is in preparation.
Data management
Data clerks in each NNU entered data into a REDcap database (http://www.project-redcap.org/), that was hosted by the Liverpool School of Tropical Medicine (LSTM). Infants were identified by a unique study number only and no personal identifiers were recorded in the database.
Data analysis
Categorical variables were presented as frequencies and percentages. Normally distributed variables were reported using means and standard deviations (SDs) and median and interquartile ranges (IQRs) were used for non-normally distributed variables. We analysed variables according to country and level of care to provide some insights into the variability between NNUs. When evaluating differences between individual NNUs, country and level of care, we considered the clinical relevance of differences in variables as well as statistical significance. Except for five variables with ≥10% missing data (maternal HIV status, hepatitis B, syphilis, gestational diabetes, and infant length of admission), the average percentage of missing data for variables ranged from 0–6.3%. The five variables with a high percentage of missing data were not included in the multivariable logistic regression analysis. Univariate and multivariable logistic regression analyses identified factors associated with mortality with data imported into Stata version 15.0 (Stata Corp). Multivariable logistic regression odds ratio plot was performed by R V3.5.2. Kaplan-Meier survival analysis was used to estimate the independent effects of gestation and birthweight on neonatal mortality. Mothers/infants with missing data for a variable were not included in the analyses.
Information about the collection of anonymised data was displayed in each NNU; no parents chose to opt-out of the study. At one of the Network sites, parents provided written informed consent; 82 parents declined consent at this site.
Results
Across the Network, anonymised data regarding 2280 infants admitted before age 48 hours were collected. Almost all variables for maternal demography and health (Table 1), labour and delivery (Table 2) and newborns (Tables 3 and 4) differed significantly amongst the NNUs.
Maternal characteristics (Table 1)
Mean age was 28.7 years (SD 6.2) and only 48 mothers were <18 years. A minority of mothers had not completed primary education (297/2146, 13.9%), over a third were unemployed or housewives (i.e. did not work out of the house) (809/2255, 37.5%) and 8.0% (175/2189) were single. Two thirds of mothers were multiparous (1495/2216, 67.4%) and 156/2222 (7.0%) had had at least one stillbirth. Over one third of mothers (824/2140, 38.5%) had attended less than four antenatal clinics and almost 1 in 5 (442/2267; 19.5%) had a multiple pregnancy. Age, education levels and employment status were lower in the Kenyan than Nigerian NNUs and in secondary than tertiary level NNUs. The proportion of single mothers was higher in Kenya than Nigeria (S1 Table in S1 File).
Availability of data from ante-natal records varied markedly between NNUs. Overall, 128/2039 (6.3%) mothers were HIV positive with a higher proportion in the Kenya than Nigeria NNUs (S1 Table in S1 File). Hepatitis B prevalence was 2.4% in Nigeria but was rarely tested in Kenya (S1 Table in S1 File). Syphilis positivity was low (2/1388; 0.1%). Pregnancy induced hypertension (363/2136, 17.0%) and antepartum haemorrhage (161/2184, 7.4%) were common complications of pregnancy but gestational diabetes was less common (34/1755; 1.9%).
Labour and delivery (Table 2)
Most births were facility-based (2128/2280; 93.3%). Risk factors for perinatal sepsis were common among mothers; 359/2151 (16.7%) had rupture of membranes ≥18 hours and 204/2159 (9.5%) had confirmed or suspected peripartum fever. More than half of mothers had received treatment with antibiotics within 24 hours before or after birth (1263/2147, 58.8%). 10.6% (115/1083) of mothers of preterm infants received four doses of antenatal dexamethasone. Almost half of deliveries were either vaginal assisted or by Caesarean section. Maternal mortality was 1.1% (24/2267).
Newborn admission characteristics (Table 3)
Most infants were male (1292/2280, 56.7%). Mean birth weight was 2.3 kg (SD 0.9); over half of admissions were LBW (1214/2182, 55.6%) and about one in five (480/2182, 22.0%) were VLBW. Methods used to assess gestation varied markedly between NNUs with last menstrual period being the most common method (1587/2245, 70.7%). Median gestation was 36 weeks (IQR 32, 39). Over half of admissions were preterm (1172/2236, 52.4%) and about one in five were very preterm (gestation <32 weeks; 483/2236; 21.6%). Nearly half of all infants received prophylactic antibiotics (1113/2252, 49.4%; defined as infants with risk factors for sepsis but without clinical features of sepsis).
Morbidity and mortality in infants (Table 4)
Jaundice was the commonest morbidity (987/2262, 43.6%; defined as an infant treated with phototherapy), with greater frequency reported from the NNUs in Nigeria. Other common conditions included suspected sepsis (955/2280, 41.9%), respiratory conditions (817/2280, 35.8%), birth asphyxia (547/2280, 24.0% in all infants but 463/1371, 33.8% among infants ≥35 weeks gestation) and congenital anomalies (128/2269, 5.6%). Of the 128 infants who were diagnosed with congenital abnormalities, 35 died during admission. These included: 10 with gastrointestinal abnormalities (1 with jejunal atresia, 1 with duodenal atresia, 1 with a gastric mass, 4 with gastroschisis, 3 with omphalocele), 6 with central nervous system abnormalities (2 with hydrocephalus, 2 with lumbar myelomeningocele, 1 with frontal encephalocele, 1 with microcephaly), 5 with cartilage and limb abnormalities (1 with achondroplasia, 1 with chrondrodysplasia, 1 congenital amputation of the right foot, 1 with genu recurvatum, 1 with congenital talipes), 4 with heart disease (both cyanotic and acyanotic), 2 with facial abnormalities (1 with cleft lip and palate, 1 with syngnathia) and 8 with other anomalies. An abdominal condition (including necrotising enterocolitis) occurred in 71/2280 (3.1%) infants with a frequency of 3.7% (45/1214) amongst LBW infants and 4.8% (23/483) amongst those with gestation <32 weeks.
Overall mortality during hospital admission was 18.7% (423/2262). Mortality was high amongst VLBW infants (222/472; 47.0%) and most extremely LBW (<1.0kg) infants died (81/104; 77.9%). Similarly, mortality was high amongst very preterm infants (197/483; 46.6%) and most extremely preterm (gestation<28 weeks) infants died (84/117; 71.8%). The majority of deaths were early neonatal deaths (335/421, 79.6%) with a median (IQR) age of death of 2 (1, 5) days (Table 4). Kaplan-Meier survival curves according to birth weight and gestation are shown in Figs 1 and 2 respectively. Survival was similar among infants with birth weight between 1.5-<2.5kg and those with weight ≥ 2.5 kg, but much lower in those with birth weight <1.5kg (log rank test P<0.001). The Kaplan-Meier survival probability estimates at 30 days were about 0.9 for infants with birthweight ≥1.5kg and 0.5 for VLBW infants. Similarly, survival was similar in infants with gestation between 32-<37 weeks and those gestation ≥37 weeks, but much lower in very preterm infants (log rank test P<0.001). The Kaplan-Meier survival probability estimates at 30 days were about 0.9 for infants with gestation ≥32 weeks and 0.5 for very preterm infants.
Of infants discharged home alive, the majority had no reported morbidities (1699/1754, 96.9%).
Factors associated with mortality in infants
In univariate analysis, the factor with the highest odds ratio for mortality was extreme prematurity (gestation <28 weeks). Other factors significantly associated with increased mortality were twin delivery, antepartum haemorrhage, place of birth other than the health facility or home (which included in the car or a mission home), mother treated with antibiotics within 24 hrs before or after birth, female infant, VLBW, smaller head circumference, shorter length, gestation 28-<32 weeks, congenital anomaly, birth asphyxia, suspected sepsis, respiratory condition and abdominal condition. Factors protective against mortality included higher maternal education and occupation status, greater number of ANC visits and delivery by caesarean section (S2 Table in S1 File).
In multivariable logistic regression analysis, gestation <28 weeks remained the factor with the highest odds of death (adjusted odds ratio [AOR] 11.58, 95% confidence interval [CI] 4.73, 28.39). The following factors were also significantly associated with increased mortality: birth weight <1.5kg (AOR 6.92, 95%CI 4.06, 11.79), congenital anomaly (AOR 4.93, 95% CI 2.42, 10.05), infant having at least one abdominal condition (AOR 2.86, 95% CI 1.40, 5.83), birth asphyxia (AOR 2.44, 95%CI 1.52, 3.92), mother receiving treatment with antibiotics within 24 hours before or after birth (AOR 1.91, 95%CI 1.28, 2.85) and infant having a respiratory condition (AOR 1.46, 95%CI 1.08, 2.28). Mother receiving 1–3 doses (AOR 0.51, 95% CI 0.28, 0.93) or four doses (AOR 0.44, 95%CI 0.21, 0.92) of antenatal dexamethasone for preterm deliveries remained protective (Fig 3).
Missing data have not been included in the analysis. Variables with response rate <90% were omitted from the analysis: HIV status (n = 2024), hepatitis B (n = 1073), syphilis (n = 1387), gestational diabetes (n = 1745), and length on admission (n = 1967). Model performance: Log likelihood = -447.87216, R2 = 0.2792, n = 1,424, P<0.001.
Among infants with birth weight <1.5kg, factors associated with neonatal mortality were being extremely preterm (AOR 8.59, 95%CI 4.12, 17.93) and mother receiving treatment with antibiotics within 24 hours before or after birth (AOR 2.83, 95%CI 1.46, 5.50). Infant being female (AOR 0.53, 95%CI 0.31, 0.92) and mother receiving 1–3 doses (AOR 0.45, 95%CI 0.20, 0.98) or 4 doses (AOR 0.28, 95%CI 0.11, 0.70) of antenatal dexamethasone for preterm deliveries were protective (S3 Table in S1 File).
Discussion
Neonatal morbidity and mortality
We report a high burden of mortality in this prospective study of hospitalised newborns admitted to secondary and tertiary NNUs in Nigeria and Kenya with an overall mortality rate of 18.7%. Variability in mortality between NNUs was marked and ranged between 4.0–28.0%. Mortality in our study is consistent with prospective studies of admissions to six NNUs in public hospitals in Eastern Ethiopia (mortality of 20.0%) [21] and to a public teaching hospital in Addis Ababa, Ethiopia (23.1%) [22]. In retrospective studies, mortality ranged from 13–38% in NNUs in Kenya [29, 30], 5.7–23.3% in Ethiopia [23, 24], 18.8% in Nigeria [25], 15.7% in Cameroon [26] and 8.2% in Eritrea [27].
Significant variation in case mix likely contributes to the marked variability in mortality between NNUs included in our study. Compared with the NNUs in Nigeria, maternal age, level of education and employment status were lower and HIV infection rates higher in Kenya. This suggests that the NNUs in Kenya served a more disadvantaged population which may be a reflection of the Free Maternity Service policy implemented in all public (government-run) hospitals in 2013 [28]. Interestingly, although this policy increased facility-based deliveries, recent data suggests that it has not significantly reduced maternal or neonatal mortality [29]. The case mix also varied between secondary and tertiary level NNUs with more women who were less educated and unemployed attending secondary level NNUs. Neonatal risk adjustment scores, using combinations of vulnerability (e.g. VLBW, prematurity), biological (e.g. common morbidities) and socioeconomic variables, will be important to compare outcomes between different NNUs, levels of care and regions and inform research and quality improvement initiatives, and are being developed specifically for low-resource settings [30].
Consistent with data for all neonatal deaths [31, 32], 80% deaths occurred in the early neonatal period (0–6 days). In resource-limited settings, shortages of skilled staff [33] who recognise danger signs and implement appropriate management strategies [34] remain a challenge in neonatal care. In addition, access to essential equipment such as continuous positive airways pressure to support complications such as respiratory distress syndrome [35] is often not available. Also, as families often incur out of pocket expenses for health care even in public health facilities, this too may hinder quality of care offered to these vulnerable infants [36].
In the multivariable analysis, the highest OR for mortality were for gestation <28 weeks (AOR 11.6, 95% CI 4.7–28.4) and LBW (AOR 6.9, 95% CI 4.1–11.8) and each occurred in about 1 in 5 babies. Estimation of gestation is a challenge in LMICs due to inadequate access to quality antenatal care [37]. Although inferior to an antenatal ultrasound scan, assessment based on date of last menstrual period, the most common method in our study, has been shown to be relatively reliable for the estimation of gestational age in LMICs [38]. Our findings are consistent with the multivariable logistic regression analysis in the prospective studies in Ethiopia, where both gestation <37 weeks and LBW were independently associated with mortality in the multicentre study [21] and gestational age below mean value (<36.6 weeks) in the single centre study [22]. In our analysis and the study by Desalaw et al., although not mutually exclusive, both prematurity and LBW were retained in the multiple regression model suggesting that preterm birth and intra-uterine growth restriction independently increase the risk of mortality. These findings highlight the potential importance of determining the pathogenesis of LBW as optimal management may vary according to underlying causes.
Congenital anomalies occurred in fewer infants (about 1 in 20) but were significantly associated with mortality (AOR 4.9; 95%CI 2.4–10.1). Although not always preventable, congenital anomalies may require referral to tertiary level care with specialised services; therefore, referral pathways and resources to provide appropriate care need to be prioritised in these settings. Abdominal conditions, including NEC, occurred less frequently (3.1% of all infants; 4.8% of infants with gestation < 32 weeks), but were also independently associated with mortality (AOR 2.9, 95%CI 1.4–5.8). NEC is a major disease of preterm infants that hinders the establishment of early nutrition. Optimising newborn feeding is particularly important in contexts where parenteral nutrition is rarely available [39] but there is a lack of pragmatic feeding trials in SSA [40].
Birth asphyxia was diagnosed in about 1 in 4 admissions (1 in 3 of those with gestation ≥35 weeks) and associated with increased mortality (AOR 2.4, 95% CI 1.5–3.9). Our findings are consistent with other tertiary referral NNUs in SSA that receive the most complicated peripartum cases [41, 42] and highlight the need for the review of both obstetric and neonatal procedures based on WHO frameworks for improving the quality of maternal and newborn care [43] particularly at referring facilities.
Most mothers (58.8%) received antibiotics within 24 hours before or after birth. Maternal risk factors for sepsis including prolonged rupture of membranes and peripartum fever were common (16.7% and 9.5% respectively) but antibiotic prescribing exceeded this suggesting that mothers were given antibiotics as a routine despite WHO recommendations [44]. In addition, nearly half of the newborns received prophylactic antibiotics. Suspected sepsis occurred frequently (42% infants) but was not retained in the final multivariable logistic regression model. This likely reflects the poor reliability of clinical diagnosis to identify true sepsis as laboratory investigations were largely unavailable in the Network NNUs. The high exposure to antibiotics amongst both mothers and infants and the fact that maternal exposure to antibiotics was independently associated with infant mortality (AOR 1.9, 95%CI 1.3–2.9) raises concerns about the development of anti-microbial resistance in these settings.
Respiratory conditions were independently associated with mortality (AOR 1.57, 95% CI1.08–2.28) and the timely administration of antenatal dexamethasone to mothers before preterm delivery to prevent or ameliorate neonatal respiratory morbidity was associated with lower mortality. However, additional cost effective interventions to prevent this high burden of respiratory illness in newborns need to be evaluated including increased coverage of maternal influenza immunisation [45, 46].
Neonatal jaundice, requiring treatment with phototherapy, was the commonest neonatal condition (43.6%) and more common in Nigeria than in Kenya. This may reflect differences in newborn care practices and/or regional differences in the frequency of disorders causing neonatal haemolysis such as glucose-6-phosphate dehydrogenase deficiency [47–50]. Although jaundice is often mild, it can progress to kernicterus spectrum disorder, death and long-term severe neurological sequelae in survivors [51–53]. Although we did not find an association between neonatal jaundice and mortality and morbidity among survivors was low, long-term follow-up of survivors may identify motor and cognitive impairments that were not apparent at discharge.
The proportion of mothers <18 years was surprisingly low particularly among the NNUs in Nigeria (0.5%). There are a number of potential reasons for this. Firstly, recruitment of infants <48 hours of age would have excluded some infants delivered at home and presenting later in the postnatal period and this group may have consisted predominantly of younger mothers. Secondly, the out of pocket expenses, particularly at the tertiary NNUs, could have been prohibitive for younger mothers, therefore hindering them from accessing specialist neonatal care. An analysis of the 2013 Nigeria Demographic and Health Survey reported that nearly two thirds of women did not deliver in health facilities and the odds of not using health services during delivery were increased among younger women, unmarried women and those from poor households [54]. Access to specialised neonatal care amongst younger and disadvantaged mothers, merits further research.
Maternal mortality was 1.1%, which is much higher than the global estimates of ~0.2% but similar to a multicentre retrospective observational study in tertiary centres in Nigeria (2.1%) [55]. Eclampsia accounted for 5 maternal deaths and pregnancy induced hypertension was the commonest maternal morbidity in the antepartum period. Pregnancy induced hypertension is also associated with adverse neonatal outcomes including preterm/LBW births and stillbirths [56]. A recent meta-analysis of over 800,000 women predominantly from hospital-based urban populations in 24 SSA countries (including Nigeria) found that hypertensive disorders in pregnancy were common with the highest prevalence rates reported from Central and West African countries [57]. The prevention, identification and management of hypertension should be prioritised in women of childbearing age and in the intrapartum care of women in SSA.
Strengths and limitations
We consider that prospective data collection, data management systems to identify and address missing data or discrepancies and strong leadership from the co-investigators at all sites enhanced the quality of our data. However, our findings have a number of limitations. Information regarding pregnancies and deliveries were extracted from health records which led to missing data for some maternal health indicators. Most of the admissions in our study were to tertiary level NNUs that are not representative of neonatal care services in Nigeria or Kenya. In settings where health care is not always free at the point of access, the population of mothers who are able to access tertiary referral level neonatal care may be more affluent. Therefore, our data may not be representative of newborns of poorer households and/or admissions to secondary care in SSA. With an observational study design, it is not possible to ascertain cause-effect relationships. Finally, we were not able to establish post-discharge outcomes which are critical for a comprehensive assessment of disease burden in this population.
Conclusion
This study provides comprehensive multicentre data on the characteristics and short-term outcomes of hospitalised newborns in SSA that will support much needed priority setting for research and quality improvement in maternal and neonatal care [58]. We have identified a high burden of preventable maternal and neonatal illnesses in Nigeria and Kenya with the highest risk of mortality amongst very preterm and VLBW infants. Our findings emphasize the importance of collaborative work involving maternal and neonatal health clinicians and researchers working in partnership with families to develop strategies to prevent adverse neonatal outcomes that are often closely linked with poor maternal health outcomes [59]. Improved prevention and management of conditions that affect very preterm and VLBW infants deserves to be a health and research priority.
Supporting information
S1 Checklist. STROBE statement—checklist of items that should be included in reports of cross-sectional studies.
https://doi.org/10.1371/journal.pone.0244109.s001
(DOCX)
S1 Data. NeoNuNet raw data.
“Demographic, clinical and outcome variables for mothers and newborns”.
https://doi.org/10.1371/journal.pone.0244109.s003
(XLS)
Acknowledgments
We would like to thank our colleagues who contributed to the clinical care and collection of data at all the neonatal units in the Network including at the University College Hospital, Ibadan; Lagos University Teaching Hospital; Massey Street Children’s Hospital, Lagos; Ahmadu Bello University Teaching Hospital, Zaria and Maitama District Hospital, Abuja in Nigeria. In Kenya they include the Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu and The Kilifi County Referral Hospital. We would also like to thank our colleagues at the Nigerian Society of Neonatal Medicine, the Kenya Paediatric Association and the Ministries of Health in Nigeria and Kenya, who provided us with support and advice as we were setting up this study. We thank the mothers for participating in this study with their infants.
Neonatal Nutrition Network members:
Isa Abdulkadir (Ahmadu Bello University, Zaria, Nigeria); Ismaela Abubakar (Liverpool School of Tropical Medicine, Liverpool, UK); Abimbola E Akindolire (College of Medicine, University of Ibadan, Nigeria); Olusegun Akinyinka (College of Medicine, University of Ibadan, Nigeria); Stephen J Allen (Liverpool School of Tropical Medicine, Liverpool, UK); Pauline EA Andang’o (Maseno University, Kenya); Graham Devereux (Liverpool School of Tropical Medicine, Liverpool, UK); Chinyere Ezeaka (Lagos University Teaching Hospital, Nigeria); Beatrice N Ezenwa (Lagos University Teaching Hospital, Nigeria); Iretiola B Fajolu (Lagos University Teaching Hospital, Nigeria); Zainab O Imam (Massey St. Children’s Hospital, Lagos, Nigeria); Kevin Mortimer (Liverpool School of Tropical Medicine, Liverpool, UK); Martha K Mwangome (KEMRI Wellcome Trust Research Programme, Kilifi, Kenya); Helen M Nabwera (Liverpool School of Tropical Medicine, Liverpool, UK); Grace M Nalwa (Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya & Maseno University, Kenya); Walter Otieno (Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya & Maseno University, Kenya); Alison W Talbert (KEMRI Wellcome Trust Research Programme, Kilifi, Kenya); Nicholas D Embleton (Newcastle University, Newcastle, UK); Olukemi O Tongo (College of Medicine, University of Ibadan, Nigeria); Dominic D Umoru (Maitama District Hospital, Abuja, Nigeria); Janneke van de Wijgert (University of Liverpool, Liverpool, UK); Melissa Gladstone (University of Liverpool, Liverpool, UK).
Open access:
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/ licenses/by/4.0/.
Data sharing:
A minimal anonymized data set necessary to replicate the study findings has been shared. Requests for access to further data should be addressed to the corresponding author.
References
- 1.
UN IGME: Levels and Trends in Child Mortallity. In. New York: UNICEF; 2019.
- 2.
Every Newborn Action Plan, An Action Plan to End Preventable Deaths [http://www.healthynewbornnetwork.org/hnn-content/uploads/Every_Newborn_Action_Plan-ENGLISH_updated_July2014.pdf]
- 3. Countdown to C: Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health. Lancet 2018, 391(10129):1538–1548. pmid:29395268
- 4.
Sustainable development goals [http://www.un.org/sustainabledevelopment/sustainable-development-goals/]
- 5. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al.: Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013, 10 Suppl 1:S2. pmid:24625129
- 6. Upadhyay RP, Martines JC, Taneja S, Mazumder S, Bahl R, Bhandari N, et al.: Risk of postneonatal mortality, hospitalisation and suboptimal breast feeding practices in low birthweight infants from rural Haryana, India: findings from a secondary data analysis. BMJ Open 2018, 8(6):e020384. pmid:29934384
- 7. Lee AC, Blencowe H, Lawn JE: Small babies, big numbers: global estimates of preterm birth. Lancet Glob Health 2019, 7(1):e2–e3. pmid:30389450
- 8. Ballot DE, Chirwa TF, Cooper PA: Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg. BMC Pediatr 2010, 10:30. pmid:20444296
- 9. Ballot DE, Chirwa T, Ramdin T, Chirwa L, Mare I, Davies VA, et al.: Comparison of morbidity and mortality of very low birth weight infants in a Central Hospital in Johannesburg between 2006/2007 and 2013. BMC Pediatr 2015, 15:20. pmid:25885283
- 10.
Global Health Observatory(GHO) data: Causes of child mortality, 2017 [https://www.who.int/gho/child_health/mortality/causes/en/ Accessed 1 July 2019]
- 11.
(UNDP) UNDP: Human Development Indices and Indicators: 2018 Statistical Update. In. New York: UNDP; 2018.
- 12.
National Population Commission N, ICF: Nigeria Demographic Health Survey. In. Abuja, Nigeria and Rockville, Maryland, USA: National Population Commission, Nigeria; 2019.
- 13.
Kenya—Neonatal mortality rate [https://knoema.com/atlas/Kenya/Neonatal-mortality-rate (Accessed 10 May 2020)]
- 14.
UN-IGME.: Levels and trends in child mortality. In. New York: UNICEF; 2018.
- 15. Kihuba E, Gathara D, Mwinga S, Mulaku M, Kosgei R, Mogoa W, et al.: Assessing the ability of health information systems in hospitals to support evidence-informed decisions in Kenya. Glob Health Action 2014, 7:24859. pmid:25084834
- 16. Adeyi O: Health System in Nigeria: From Underperformance to Measured Optimism. Health Systems and Reform 2016, 2(4):285–289. pmid:31514723
- 17.
WHO, UNICEF: Progress Report. Reaching every newborn national 2020 milestones. In.; 2018.
- 18. Akindolire AE, Tongo O, Dada-Adegbola H, Akinyinka O: Etiology of early onset septicemia among neonates at the University College Hospital, Ibadan, Nigeria. J Infect Dev Ctries 2016, 10(12):1338–1344. pmid:28036314
- 19. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, et al.: Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis 2014, 14(8):731–741. pmid:24974250
- 20.
Ministry of Health K: Basic paediatric protocols for ages up to 5 years. In., Fourth edn. Nairobi, Kenya: Ministry of Health, Kenya; 2016.
- 21. Desalew A, Sintayehu Y, Teferi N, Amare F, Geda B, Worku T, et al.: Cause and predictors of neonatal mortality among neonates admitted to neonatal intensive care units of public hospitals in eastern Ethiopia: a facility-based prospective follow-up study. BMC Pediatr 2020, 20(1):160. pmid:32290819
- 22. Tekleab AM, Amaru GM, Tefera YA: Reasons for admission and neonatal outcome in the neonatal care unit of a tertiary care hospital in Addis Ababa: a prospective study. Res Reports Neonatol 2016, 2016(6):17–23.
- 23. Demisse AG, Alemu F, Gizaw MA, Tigabu Z: Patterns of admission and factors associated with neonatal mortality among neonates admitted to the neonatal intensive care unit of University of Gondar Hospital, Northwest Ethiopia. Pediatric Health Med Ther 2017, 8:57–64.
- 24. Worku B, Kassie A, Mekasha A, Tilahun B, Worku A: A. Predictors of early neonatal mortality at a neonatal intensive care unit of a specialized referral teaching hospital in Ethiopia. J Health Dev 2012, 26(3):200–207.
- 25. Elizabeth IU, Oyetunde MO: Pattern of diseases and care outcomes of neonates admitted in special care baby unit of university college hospital, Ibadan, Nigeria from 2007 to 2011. IOSR J Nurs Health Sci 2015, 4(3):62–71.
- 26. Ndombo PK, Ekei QM, Tochie JN, Temgoua MN, Angong FTE, Ntock FN, et al.: A cohort analysis of neonatal hospital mortality rate and predictors of neonatal mortality in a sub-urban hospital of Cameroon. Ital J Pediatr 2017, 43(1):52. pmid:28583154
- 27. Shah S, Zemichael O, Meng HD: Factors associated with mortality and length of stay in hospitalised neonates in Eritrea, Africa: a cross-sectional study. BMJ Open 2012, 2(5). pmid:22983873
- 28.
Free maternal health care policy launch [http://www.knchr.org/Portals/0/EcosocReports/Implementing%20Free%20Maternal%20Health%20Care%20in%20Kenya.pdf (Accessed 5 December 2019)]
- 29. Gitobu CM, Gichangi PB, Mwanda WO: The effect of Kenya's free maternal health care policy on the utilization of health facility delivery services and maternal and neonatal mortality in public health facilities. BMC Pregnancy Childbirth 2018, 18(1):77. pmid:29580207
- 30. Medvedev MM, Brotherton H, Gai A, Tann C, Gale C, Waiswa P, et al.: Development and validation of a simplified score to predict neonatal mortality risk among neonates weighing 2000 g or less (NMR-2000): an analysis using data from the UK and The Gambia. Lancet Child Adolesc Health 2020, 4(4):299–311. pmid:32119841
- 31. Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering T: 4 million neonatal deaths: when? Where? Why? Lancet 2005, 365(9462):891–900. pmid:15752534
- 32. Lehtonen L, Gimeno A, Parra-Llorca A, Vento M: Early neonatal death: A challenge worldwide. Semin Fetal Neonatal Med 2017, 22(3):153–160. pmid:28238633
- 33. Aluvaala J, Nyamai R, Were F, Wasunna A, Kosgei R, Karumbi J, et al.: Assessment of neonatal care in clinical training facilities in Kenya. Arch Dis Child 2015, 100(1):42–47. pmid:25138104
- 34. Murphy GAV, Gathara D, Mwaniki A, Nabea G, Mwachiro J, Abuya N, et al.: Nursing knowledge of essential maternal and newborn care in a high-mortality urban African setting: A cross-sectional study. J Clin Nurs 2019, 28(5–6):882–893. pmid:30357971
- 35. Dewez JE, van den Broek N: Continuous positive airway pressure (CPAP) to treat respiratory distress in newborns in low- and middle-income countries. Trop Doct 2017, 47(1):19–22. pmid:26864235
- 36. Enweronu-Laryea CC, Andoh HD, Frimpong-Barfi A, Asenso-Boadi FM: Parental costs for in-patient neonatal services for perinatal asphyxia and low birth weight in Ghana. PLoS One 2018, 13(10):e0204410. pmid:30312312
- 37. Unger H, Thriemer K, Ley B, Tinto H, Traore M, Valea I, et al.: The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa. BMC Pregnancy Childbirth 2019, 19(1):12. pmid:30621604
- 38. Rosenberg RE, Ahmed AS, Ahmed S, Saha SK, Chowdhury MA, Black RE, et al.: Determining gestational age in a low-resource setting: validity of last menstrual period. J Health Popul Nutr 2009, 27(3):332–338. pmid:19507748
- 39. Alganabi M, Lee C, Bindi E, Li B, Pierro A: Recent advances in understanding necrotizing enterocolitis. F1000Res 2019, 8. pmid:30740215
- 40. Akindolire A, Talbert A, Sinha I, Embleton N, Allen S, Neonatal Nutrition N: Evidence that informs feeding practices in very low birthweight and very preterm infants in sub-Saharan Africa: an overview of systematic reviews. BMJ Paediatr Open 2020, 4(1):e000724. pmid:32821859
- 41. Owusu BA, Lim A, Makaje N, Wobil P, SameAe A: Neonatal mortality at the neonatal unit: the situation at a teaching hospital in Ghana. Afr Health Sci 2018, 18(2):369–377. pmid:30602964
- 42. Orsido TT, Asseffa NA, Berheto TM: Predictors of Neonatal mortality in Neonatal intensive care unit at referral Hospital in Southern Ethiopia: a retrospective cohort study. BMC Pregnancy Childbirth 2019, 19(1):83. pmid:30819143
- 43.
WHO: Standards for improving quality of maternal and newborn care in health facilities In. Geneva: WHO; 2016.
- 44.
WHO: WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections. In. Geneva, Switzerland: WHO; 2015.
- 45. Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, et al.: Maternal immunization: where are we now and how to move forward? Ann Med 2018, 50(3):193–208. pmid:29308916
- 46. Nunes MC, Madhi SA: Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy. F1000Res 2018, 7:122. pmid:29445450
- 47. Owa JA, Dawodu AH: Neonatal jaundice among Nigerian preterm infants. West Afr J Med 1990, 9(4):252–257. pmid:2083201
- 48. Lippi G, Mattiuzzi C: Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders. Acta Haematol 2019:1–7. pmid:31550707
- 49. Osuorah CDI, Ekwochi U, Asinobi IN: Clinical evaluation of severe neonatal Hyperbilirubinaemia in a resource-limited setting: a 4-year longitudinal study in south-East Nigeria. BMC Pediatr 2018, 18(1):202. pmid:29935542
- 50. Engwa GA, Unaegbu M, Unachukwu MN, Njoku MC, Agbafor KN, Mbacham WF, et al.: Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria. BMC Res Notes 2017, 10(1):721. pmid:29221497
- 51. Olusanya BO, Kaplan M, Hansen TWR: Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health 2018, 2(8):610–620. pmid:30119720
- 52. Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand MA, Lee BW, et al.: Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open 2017, 1(1):e000105. pmid:29637134
- 53. Olusanya BO, Teeple S, Kassebaum NJ: The Contribution of Neonatal Jaundice to Global Child Mortality: Findings From the GBD 2016 Study. Pediatrics 2018, 141(2). pmid:29305393
- 54. Adedokun ST, Uthman OA: Women who have not utilized health Service for Delivery in Nigeria: who are they and where do they live? BMC Pregnancy Childbirth 2019, 19(1):93. pmid:31138198
- 55. Ntoimo LF, Okonofua FE, Ogu RN, Galadanci HS, Gana M, Okike ON, et al.: Prevalence and risk factors for maternal mortality in referral hospitals in Nigeria: a multicenter study. Int J Womens Health 2018, 10:69–76. pmid:29440934
- 56. Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V: Pregnancy-Induced hypertension. Hormones (Athens) 2015, 14(2):211–223. pmid:26158653
- 57. Noubiap JJ, Bigna JJ, Nyaga UF, Jingi AM, Kaze AD, Nansseu JR, et al.: The burden of hypertensive disorders of pregnancy in Africa: A systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2019, 21(4):479–488. pmid:30848083
- 58. English M, Karumbi J, Maina M, Aluvaala J, Gupta A, Zwarenstein M, et al.: The need for pragmatic clinical trials in low and middle income settings—taking essential neonatal interventions delivered as part of inpatient care as an illustrative example. BMC Med 2016, 14:5. pmid:26782822
- 59.
WHO., UNICEF.: Every Newborn: An action plan to end preventable newborn deaths. In. Geneva: World Health Organisation; 2014.